Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis

← catalyst calendar

NCT05891600

Sponsored by Pfizer (industry) · PFE — their whole pipeline →.

Phase
Status
Terminated
Study type
Observational
Enrollment
60actual
Sites
1
Country
Colombia

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

The study was terminated following a comprehensive review of the collected data and an assessment of the study's completeness. This decision was made to maintain scientific standards and ethical conduct, and to prevent potentially inaccurate results

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-06-06actualWhen the study began enrolling
Primary completion2025-05-30actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-05-30actualThe whole study's end, after follow-up
First posted2023-06-07actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-11-20actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Rheumatoid Arthritis

Intervention

  • Drug: Etaneracept Smartclic

Primary outcomes

what the primary-completion date above is the date OF
Adherence (Pharmacy claims source)
measured Baseline through week 40
Change From Baseline in Disease Activity Score Based on 28-joints Count with ESR (DAS28-ESR) at 40 week
measured Baseline, Week 40
Change From Baseline in Functional status Based on Multidimensional Health Assessment Questionnaire (MDHAQ) at 40 week
measured Baseline, Weeks 40

Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed